Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel
about
sameAs
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesThe signaling role of CD40 ligand in platelet biology and in platelet component transfusionTargeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune DisordersEnhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failureClopidogrel for the secondary prevention of strokeResistance to antiplatelet drugs: current status and future researchFlow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass graftingP2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteriesAspirin and clopidogrel resistance: consideration and managementOral antiplatelet therapy and percutaneous coronary interventionClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseEffects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteersClopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery diseaseP2Y12 receptors: structure and functionClopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness.Inflammation and thrombosis in cardiovascular disease.Minding the gaps to promote thrombus growth and stabilityMultifunctional CD40L: pro- and anti-neoplastic activity.Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disordersFunctional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 moleculesValproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individualsContact-dependent signaling during the late events of platelet activation.Premature labor: a state of platelet activation?Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndromeCD40 ligand: a novel target in the fight against cardiovascular disease.Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.Triggering CD40 on endothelial cells contributes to tumor growthPotential role for immunomodulatory therapy in atherosclerotic plaque stabilisation.Inhibition of angiogenesis by platelets in systemic sclerosis patients.Pathobiology and cell interactions of platelets in diabetes.Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.AICAR reduces the collagen-stimulated secretion of PDGF-AB and release of soluble CD40 ligand from human platelets: Suppression of HSP27 phosphorylation via p44/p42 MAP kinase.Platelet receptors and signaling in the dynamics of thrombus formation.Platelet P2Y12 receptor inhibition by thienopyridines: status and future.Mediation of transitional B cell maturation in the absence of functional Bruton's tyrosine kinase.Review: Antiplatelet drugs: what comes next?The CD40-CD40L system in cardiovascular disease.Antiplatelet therapy and vascular disease: an update.
P2860
Q26739670-5C3F39DC-175F-44B9-BFBF-897190C489C1Q26863134-265CA795-9A8A-48B0-81B3-79203D84FB71Q27010594-96E51BB4-D7BA-4E9A-8D14-4A2CAF0B9C55Q28071325-DD3CE449-26F8-4C88-939B-13119D1A6E69Q28166019-68CD1406-6204-4E15-9662-81B85EF291E6Q28176560-04E15626-E3F5-4873-88AD-FA0D1D056A17Q28192298-873B0DCC-0479-4DD4-B450-11CD4A1B27E5Q28192855-6EDFA808-0D4C-472A-8489-B2166286676AQ28196936-19CDD0C3-B8C0-4BBF-9522-6D0B9B980D0BQ28200610-FB075C42-23ED-4CB8-8F67-1C9201059559Q28217724-0A40C2E5-F324-4BDD-8625-FE0838EB5B33Q28218124-F7A1438B-D1B9-4ECB-87A3-EADD65C735A1Q28218884-4562CF77-3623-48DF-A277-F19C3771D478Q28219643-907C9DDC-270D-4F07-A0E6-D39F84554CF2Q28264649-43881115-D70B-4224-8A95-308CD26F6946Q30415074-2DA6F8DA-4CB5-479A-A8BF-46231A5C78D6Q33864069-CA11BD22-E131-423A-ACA7-4042CF2F53A8Q34160242-52EEDA2E-77FC-4C6C-92DD-B06327EC2A70Q34422566-4166A302-4D48-404F-90F1-A049DB72F175Q34517239-FBE70C59-A441-453B-9256-4FF05941A3E1Q34637068-F63DD0A5-A4C5-4D12-A857-48BDB6871B59Q34652709-A5482CFD-3178-4BA0-A0A1-AEF4C682ECD0Q35181668-BC7C1980-045E-4A8E-97B2-809053A10ADCQ35185510-5CFA5470-4A4F-48A3-8B74-A426C91766FCQ35583381-C0CB8B64-F9EE-4DF4-827F-CE381CD9EC5CQ35848866-912BFBD7-50AB-4D64-B9FE-769AEE75A5B7Q35932082-65C66F73-15C2-4580-9F97-72DBC6C91CC9Q36040667-72C4D415-1916-4869-B0FB-881F3D67939AQ36228064-649A4903-A230-4C31-8843-CB12289E2136Q36283698-9D422C1C-810B-492F-93A9-2284B05243A6Q36301680-1248E978-D132-477D-A95A-50EE76E57758Q36320564-E667E81E-752B-482C-9659-E6DE6FA8C639Q36991109-FD1719CA-93E1-47B9-A0CF-D2E028AB6BFDQ37108786-3BD8D2DC-F04C-4ADF-A6E3-E6D065F71773Q37175605-F2903287-C0D6-4500-8C2A-34478CE1EBC7Q37579228-D88E63F0-37F4-457B-9A12-8D00D7FB894AQ37737830-56BD28E9-3E73-4775-8686-96D0D5D886BFQ37809630-F456BD4E-E462-4107-9A31-789BB240BAF3Q37829738-644E1D74-2473-4C8F-B96C-89EA67D71817Q37838100-BFEEBB66-85D3-4C02-83A4-52E45EC9B179
P2860
Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@ast
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@en
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@nl
type
label
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@ast
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@en
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@nl
prefLabel
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@ast
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@en
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@nl
P2093
P3181
P1433
P1476
Platelet CD40 ligand (CD40L)-- ...... and inhibition by clopidogrel
@en
P2093
P3181
P356
10.1080/09537100020031207
P407
P577
2001-03-01T00:00:00Z